Towards Healthcare
Analgesics Market to Lead USD 80.26 Billion by 2034

Analgesics Market 2025 Expansion Driven by Self-Medication and AI

According to market projections, the global analgesics market, valued at USD 43.8 billion in 2024, is anticipated to reach USD 80.26 billion by 2034, growing at a CAGR of 6.24% over the next decade. The rising prevalence of chronic pain and the availability of OTC drugs bolster market growth. North America dominated the global market due to the presence of key players and advanced healthcare infrastructure.

  • Insight Code: 6197
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The analgesics market stands at USD 46.53 billion in 2025 and is expected to reach USD 80.26 billion by 2034, growing at a CAGR of 6.24% from 2024 to 2034.

North America is leading the analgesics market share 35% due to the availability of state-of-the-art research and development facilities, the presence of key players, and favorable regulatory policies.

Some key players include Johnson & Johnson, Bayer AG, AbbVie, Inc., and Cadila Healthcare.

Opioid analgesics work by activating an area of nerve cells in the brain and body called opioid receptors that block pain signals between the brain and the body.

World Health Organization, Food and Drug Administration, Government of Canada, Press Information Bureau